GlassScriptPhysician profile
Marshall Gillette
NPI 1790172211
$16,582.86
in general payments reported to CMS, 2019-2025
7 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2021: $765 · 2022: $2,045 · 2023: $6,116 · 2024: $4,322 · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,659 · Consulting Fee: $3,815 · Food and Beverage: $2,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,659.32 |
| Consulting Fee | $3,815.00 |
| Food and Beverage | $2,851.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,654.87 | 2021-2025 | Pro, Gamma, Pangea |
| Acumed LLC | $4,182.97 | 2023 | Acumed, Arcphix System |
| Medartis INC. | $4,066.01 | 2022-2024 | Aptus |
| Cdc Medical LLC | $1,447.00 | 2019 | |
| Depuy Synthes Sales INC. | $120.77 | 2021 | |
| Carbofix Orthopedics INC | $82.17 | 2022 | |
| Medacta USA, INC. | $29.07 | 2025 | Gmk Revision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Gillette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.